ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of Acute Leukemia (Sample3)
Published: 5 March 2018| Version 1 | DOI: 10.17632/ktm8tb6by8.1
Contributor:
tamara maesDescription
Sample3 THP-1 H3K4me2 ChIPSeq Data after ORY-1001 treatment
Files
Institutions
Oryzon
Categories
Epigenetics